Progenity Files for IPO, Seeks to Raise up to $100M
The company said that a large portion of the offering's proceeds would be used to end criminal and civil investigations over its past billing practices.
Startup Cadex Genomics Raises $1.5M
The firm's lead product is a blood-based assay, called Alibrex, which uses PCR technology to monitor stage IV solid tumor cancer therapy.
Saladax Licenses Janssen Pharmaceutica IP for Antipsychotic Drug Tests
Saladax will have the patent rights to Janssen Pharmaceutica's tests that determine drug levels in patients undergoing treatment with antipsychotic drugs.